Nature's Derivative(s) as Alternative Anti-Alzheimer's Disease Treatments

Anuja Sharma1, Yatender Kumar1

  • 1Department of Biological Sciences and Engineering (BSE), Netaji Subhas University of Technology (NSUT), Formerly Netaji Subhas Institute of Technology (NSIT), Azad Hind Fauz Marg, New Delhi, India.

Insights

Alternative therapies like Ayurveda, meditation, and exercise show promise for managing Alzheimer's disease (AD). These ancient practices offer safer, complementary approaches to conventional treatments for this neurodegenerative condition.

Area of Science:

  • Neuroscience
  • Integrative Medicine
  • Gerontology

Background:

  • Alzheimer's disease (AD) is a growing global health crisis, projected to affect 135 million by 2050.
  • Current AD treatments offer limited efficacy, symptom management, and potential side effects.
  • The economic burden of AD care is substantial for patients and families.

Purpose of the Study:

  • To review alternative and complementary therapies for Alzheimer's disease management.
  • To explore the potential of traditional practices in combating AD.
  • To highlight the need for safer, more effective AD treatment strategies.

Main Methods:

  • Review of Ayurvedic medicine, traditional Chinese medicine, meditation, and exercise for AD.
  • Analysis of reported benefits of specific Ayurvedic drugs (e.g., turmeric, Brahmi, Ashwagandha).
  • Inclusion of stress management, physical activity, acupuncture, and dietary interventions.

Main Results:

  • Ayurvedic remedies, meditation, exercise, and acupuncture demonstrate potential anti-AD effects.
  • These alternative therapies are reported to be beneficial in managing AD.
  • Combined use of vitamins and natural diets may play a role in AD prevention and management.

Conclusions:

  • Alternative strategies offer a promising avenue for preventing, treating, and managing Alzheimer's disease.
  • These therapies represent a potential stepping-stone towards better AD care.
  • Further research into integrative approaches is warranted for improved patient outcomes.

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
709
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
468
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
890
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.2K